Article
Can research at the end of life be a useful tool to advance HIV cure?
15 Oct 2016
Abstract excerpt
Modern antiretroviral therapy (ART) has saved millions of years of life [1], but it cannot eradicate latently infected cells [2,3]. The replication-competent provirus that remains during ART represents the major barrier to curing HIV [4]. Most of this latent reservoir resides in solid tissues and not in circulating blood, and we have yet to fully define the sanctuary sites of HIV persistence [5]. Timothy Ray...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
